mephentermine has been researched along with Arteriosclerosis in 1 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KOLOMEYER, N | 1 |
1 other study available for mephentermine and Arteriosclerosis
| Article | Year |
|---|---|
A clinical evaluation of mephentermine sulfate and pentylenetetrazol as stimulant therapy for the geriatric patient.
Topics: Aged; Arteriosclerosis; Central Nervous System Agents; Central Nervous System Stimulants; Humans; Me | 1958 |